Jump to main content
eTG Complete
eTG Complete
Index
  1. Home
  2. Psychotropic
  3. Practical information on using psychotropics
  4. Psychotropic use during pregnancy
  5. References
  6. References: Melatonin use during pregnancy
  • Psychotropic
    • Informed consent and shared decision making for a person with a psychiatric disorder
    • Acute behavioural disturbance
    • Anxiety and associated disorders
    • Attention deficit hyperactivity disorder
    • Challenging behaviour in autism spectrum disorder
    • Bipolar disorder
    • Delirium
    • Dementia
    • Depressive disorders
    • Disruptive behaviour disorders
    • Eating disorders
    • Grief
    • Insomnia, circadian rhythm disorders and parasomnias
    • Personality disorder
    • Psychoses
    • Postpartum psychosis
    • Suicide risk
    • Tourette syndrome
    • Trauma- and stressor-related disorders
    • Practical information on using psychotropics
      • Off-label prescribing for psychiatric disorders
      • Adherence to psychotropics
      • Psychotropic use in children
      • Psychotropic use in females of childbearing potential
      • Psychotropic use during pregnancy
        • What is covered in this topic?
        • Overview of psychotropic pregnancy data
        • Principles of psychotropic use during pregnancy
        • Antidepressant use during pregnancy
        • Antipsychotic use during pregnancy
        • Benzodiazepine use during pregnancy
        • Lamotrigine for psychiatric disorders during pregnancy
        • Lisdexamfetamine use for psychiatric disorders during pregnancy
        • Lithium use during pregnancy
        • Melatonin use during pregnancy
        • Pregabalin use for psychiatric disorders during pregnancy
        • Sodium valproate or carbamazepine for psychiatric disorders during pregnancy
        • Suvorexant use during pregnancy
        • Zolpidem or zopiclone use during pregnancy
        • Complementary medicine use for psychiatric disorders during pregnancy
        • References
          • References: Overview of psychotropic pregnancy data
          • References: Principles of psychotropic use during pregnancy
          • References: Antidepressant use during pregnancy
          • References: Antipsychotic use during pregnancy
          • References: Benzodiazepine use during pregnancy
          • References: Lamotrigine for psychiatric disorders during pregnancy
          • References: Lisdexamfetamine use for psychiatric disorders during pregnancy
          • References: Lithium use during pregnancy
          • References: Melatonin use during pregnancy
          • References: Pregabalin use for psychiatric disorders during pregnancy
          • References: Sodium valproate or carbamazepine for psychiatric disorders during pregnancy
          • References: Suvorexant use during pregnancy
          • References: Zolpidem or zopiclone use during pregnancy
          • References: Complementary medicine use for psychiatric conditions during pregnancy
      • Psychotropic use while breastfeeding
      • Antidepressant adverse effects
      • Switching antidepressants
      • Stopping an antidepressant
      • Principles of using irreversible nonselective monoamine oxidase inhibitors (MAOIs)
      • Principles of antipsychotic use
      • Antipsychotic adverse effects
      • Switching antipsychotics
      • Stopping an antipsychotic
    • Nonpharmacological therapies for psychiatric disorders

References: Melatonin use during pregnancy

  • Amer MR, Cipriano GC, Venci JV, Gandhi MA. Safety of popular herbal supplements in lactating women. J Hum Lact 2015;31(3):348–53. https://www.ncbi.nlm.nih.gov/pubmed/25881578
  • Chaudhry SK, Susser LC. Considerations in treating insomnia during pregnancy: a literature review. Psychosomatics 2018;59(4):341–8. https://www.ncbi.nlm.nih.gov/pubmed/29706359
  • Contact us
  • Conditions of use and disclaimer
  • Privacy policy
  • Copyright permission
  • Support and FAQ

www.tg.org.au
All site content © Therapeutic Guidelines Limited 2020. Therapeutic Guidelines Limited, Ground Floor, 473 Victoria Street, West Melbourne, Victoria 3003, Australia © Therapeutic Guidelines Ltd (eTG August 2020)

Created: No created attribute found. Modified: No revised attribute found. (HW Diagnostics)